NOTCH1 and acute lymphoblastic leukemia: Here, we further explored the interplay between Notch signaling and the above-mentioned chromatin modifiers to gain further insights into molecular mechanisms driving aberrant expression and activation of Notch3 receptor in T-ALL even in contexts lacking Notch1 activation, with the aim to reveal novel potential therapeutic targets relevant in this hematological cancer.